JamesDavidsonFinkleaJr.MD

Pulmonology • Dallas, TX

Critical Care Medicine, Pleural Disease

Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center

Join to view full profile

Dr. Finklea is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Finklea's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-0599

Fax+1 214-645-3297
Is this information wrong?

Education & Training

Emory University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Internal Medicine, 2006 - 2009
John Peter Smith Hospital (Tarrant County Hospital District)Residency, Family Medicine, 2004 - 2006
University of Texas Medical Branch School of MedicineClass of 2004

Certifications & Licensure

TX State Medical License 2008 - 2025
OK State Medical License 2022 - 2024
AR State Medical License 2023 - 2024
GA State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

2 citations
Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.
Angela Wang, MinJae Lee, Ashley Keller, Sarah Jian, Karen Lowe, James D Finklea, Raksha Jain> ;Journal of Cystic Fibrosis. 2024 Jan 1
7 citations
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Patrick James Nolan, Raksha Jain, Leah Cohen, James D. Finklea, Tiffeny T. Smith> ;Diagnostic Microbiology and Infectious Disease. 2021 Feb 1
End-of-Life Care in Cystic Fibrosis: Comparing Provider Practices Based on Lung Transplant Candidacy.
Allison Virginia Lange, Ali Rueschhoff, Stephanie Terauchi, Leah Cohen, Joan S. Reisch, Raksha Jain, James D. Finklea> ;Journal of Palliative Medicine. 2020 May 7
17 citations
Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam.
Stan D. Atkin, Shadaan Abid, Michael L. Foster, Moumita Bose, Ashley Keller, Rita Hollaway, Helio S. Sader, David E. Greenberg, James D. Finklea, Mariana Castanheira, ...> ;Infection and Drug Resistance. 2018 Sep 17
13 citations
Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
James D. Finklea, Rita Hollaway, Karen Lowe, Francesca Lee, Jade Le, Raksha Jain> ;Diagnostic Microbiology and Infectious Disease. 2018 Sep 1
15 citations
Lung transplantation and gender effects on survival of recipients with cystic fibrosis
Deepa Raghavan, Ang Gao, Chul Ahn, Vaidehi Kaza, James D. Finklea, Fernando Torres, Raksha Jain> ;The Journal of Heart and Lung Transplantation. 2016 Dec 1
6 citations
Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study
Jenny E. Han, Antoine R Trammell, James D. Finklea, Timothy Udoji, Daniel D. Dressler, Eric G. Honig, Prasad Abraham, Douglas S. Ander, George Cotsonis, Greg S. Martin...> ;Journal of Graduate Medical Education. 2014 Sep 4
81 citations
Vitamin D and Chronic Lung Disease: A Review of Molecular Mechanisms and Clinical Studies
James D. Finklea, Ruth E. Grossmann, Vin Tangpricha> ;Advances in Nutrition. 2011 May 1
32 citations
Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis
James D. Finklea, Gul Khan, Sheree Thomas, Juhee Song, Dennis Myers, Alejandro C. Arroliga> ;Respiratory Medicine. 2010 Jun 1
Join now to see all

Journal Articles

Antimicrobial Susceptibility Study Ceftolozane/tazobactam Sensitivity Patterns in Pseudomonas Aeruginosa Isolates Recovered from Sputum of Cystic Fibrosis Patients
James D Finklea, Raksha Jain, Karen Lowe, Francesca Lee, ScienceDirect

Hospital Affiliations

University of Texas Southwestern Medical CenterDallas, Texas
William P. Clements, Jr. University HospitalDallas, Texas